Collection

Coronavirus (COVID-19): clinical guidance

Clinical guidance for health and social care professionals.


Documents

Further information

Guidance for health professionals and health protection teams can also be found at Health Protection Scotland.

Rapid policy statement – Paliviuzumab for respiratory synctical virus

Update to the interim clinical commissioning policy – Remdesivir

COVID-19 Therapeutic alert: Letter re interim position statement about the use of Tocilizumab for adult patients admitted to ICU with COVID-19 Pneumonia

Interim position statement: Tocilizumab for patients admitted to ICU with COVID-19 pneumonia (adults)

Pfizer BioNTech COVID-19 Vaccine – Doses per Vial (circular)

Pfizer BioNTech COVID-19 Vaccine – Doses per Vial (database)

Information about the use of azithromycin in the management of COVID-19 (circular)

Information about the use of azithromycin in the management of COVID-19 (database)

information about therapeutic anticoagulation (Heparin) in the management of severe COVID-19 (SARS-CoV-2 Positive) patients (circular)

information about therapeutic anticoagulation (Heparin) in the management of severe COVID-19 (SARS-CoV-2 Positive) patients (database)

COVID-19 Therapeutic Alert – Interleukin-6 inhibitors (Tocilizumab or Sarilumab) for adult patients admitted to ICU with COVID-19 pnuemonia (letter).

COVID-19 Therapeutic Alert – Interleukin-6 inhibitors (Tocilizumab or Sarilumab) for adult patients admitted to ICU with COVID-19 pnuemonia (database entry)

AstraZeneca COVID-19 Vaccine - Doses per vial clarification on update to MHRA Information to Healthcare Professionals (letter)

AstraZeneca COVID-19 Vaccine - Doses per vial clarification on update to MHRA Information to Healthcare Professionals (database)